BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19222463)

  • 1. Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.
    Hartmann-Petersen S; Tammi RH; Tammi MI; Kosma VM
    Br J Dermatol; 2009 Jun; 160(6):1251-7. PubMed ID: 19222463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
    Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
    Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
    Impola U; Jeskanen L; Ravanti L; Syrjänen S; Baldursson B; Kähäri VM; Saarialho-Kere U
    Br J Dermatol; 2005 Apr; 152(4):720-6. PubMed ID: 15840104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
    Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
    Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan, CD44 and versican in epidermal keratinocyte tumours.
    Karvinen S; Kosma VM; Tammi MI; Tammi R
    Br J Dermatol; 2003 Jan; 148(1):86-94. PubMed ID: 12534600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
    Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U
    J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
    Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
    Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma.
    Muchemwa FC; Nakatsura T; Ihn H; Kageshita T
    Br J Dermatol; 2006 Sep; 155(3):582-5. PubMed ID: 16911285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
    Peng ST; Su CH; Kuo CC; Shaw CF; Wang HS
    Int J Oncol; 2007 Nov; 31(5):1119-26. PubMed ID: 17912438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
    Tilakaratne WM; Kobayashi T; Ida-Yonemochi H; Swelam W; Yamazaki M; Mikami T; Alvarado CG; Shahidul AM; Maruyama S; Cheng J; Saku T
    J Oral Pathol Med; 2009 Apr; 38(4):348-55. PubMed ID: 19239574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer.
    Young LC; Listgarten J; Trotter MJ; Andrew SE; Tron VA
    Br J Dermatol; 2008 Jan; 158(1):59-69. PubMed ID: 17970804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-oligosaccharide-induced transcription of metalloproteases.
    Fieber C; Baumann P; Vallon R; Termeer C; Simon JC; Hofmann M; Angel P; Herrlich P; Sleeman JP
    J Cell Sci; 2004 Jan; 117(Pt 2):359-67. PubMed ID: 14657275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
    Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
    Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
    Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
    J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
    Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
    Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.